 |
Previous Article | Next Article 
The Journal of Neuroscience, July 15, 1998, 18(14):5456-5462
Leukemia Inhibitory Factor Is an Anti-Inflammatory and
Analgesic Cytokine
Lisa R.
Banner1,
Paul
H.
Patterson1,
Andrew
Allchorne2,
Steve
Poole3, and
Clifford J.
Woolf2, 4
1 Division of Biology, California Institute of
Technology, Pasadena, California 91125, 2 Department of
Anatomy and Developmental Biology, University College London, London
WC1E 6BT, England, 3 Division of Endocrinology, National
Institute for Biological Standards and Control, Herts EN6 3QG, England,
and 4 Department of Anesthesiology, Massachusetts General
Hospital and Harvard Medical School, Charlestown, Massachusetts 02129
The mRNA for leukemia inhibitory factor (LIF), a neuroimmune
signaling molecule, is elevated during skin inflammation produced by
intraplantar injection of complete Freund's adjuvant (CFA). Moreover,
although LIF knock-out mice display normal sensitivity to cutaneous
mechanical and thermal stimulation compared with wild-type mice, the
degree of CFA-induced inflammation in mice lacking LIF is enhanced in
spatial extent, amplitude, cellular infiltrate, and interleukin
(IL)-1 and nerve growth factor (NGF) expression. Conversely, local
injection of low doses of recombinant LIF diminishes mechanical and
thermal hypersensitivity as well as the IL-1 and NGF expression
induced by CFA. These data show that upregulation of LIF during
peripheral inflammation serves a key, early anti-inflammatory role and
that exogenous LIF can reduce inflammatory hyperalgesia.
Key words:
pain; inflammation; edema; hyperalgesia; primary sensory
neuron; analgesia
Copyright © 1998 Society for Neuroscience 0270-6474/98/18145456-07$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
R. A. Linker, N. Kruse, S. Israel, T. Wei, S. Seubert, A. Hombach, B. Holtmann, F. Luhder, R. M. Ransohoff, M. Sendtner, et al.
Leukemia Inhibitory Factor Deficiency Modulates the Immune Response and Limits Autoimmune Demyelination: A New Role for Neurotrophic Cytokines in Neuroinflammation
J. Immunol.,
February 15, 2008;
180(4):
2204 - 2213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Morikawa, S. Tamura, K.-i. Minehata, P. J. Donovan, A. Miyajima, and E. Senba
Essential Function of Oncostatin M in Nociceptive Neurons of Dorsal Root Ganglia
J. Neurosci.,
February 25, 2004;
24(8):
1941 - 1947.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. B. J. Cafferty, N. J. Gardiner, I. Gavazzi, J. Powell, S. B. McMahon, J. K. Heath, J. Munson, J. Cohen, and S. W. N. Thompson
Leukemia Inhibitory Factor Determines the Growth Status of Injured Adult Sensory Neurons
J. Neurosci.,
September 15, 2001;
21(18):
7161 - 7170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zhu, K. Oishi, S. Chul Lee, and P. H. Patterson
Studies Using Leukemia Inhibitory Factor (LIF) Knockout Mice and a LIF Adenoviral Vector Demonstrate a Key Anti-Inflammatory Role for This Cytokine in Cutaneous Inflammation
J. Immunol.,
February 1, 2001;
166(3):
2049 - 2054.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Chesnokova, A. Kariagina, and S. Melmed
Opposing effects of pituitary leukemia inhibitory factor and SOCS-3 on the ACTH axis response to inflammation
Am J Physiol Endocrinol Metab,
May 1, 2002;
282(5):
E1110 - E1118.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|